Fundamental Analysis of CANO HEALTH INC(NYSE:CANO) stock

Fundamental Rating

CANO gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 117 industry peers in the Health Care Providers & Services industry. CANO may be in some trouble as it scores bad on both profitability and health. CANO is valied quite expensively at the moment, while it does show a decent growth rate.

Quickly go to:

1. Profitability

1.1 Basic Checks

CANO had negative earnings in the past year.

CANO had a negative operating cash flow in the past year.

1.2 Ratios

With a Return On Assets value of -47.69%, CANO is not doing good in the industry: 85.22% of the companies in the same industry are doing better.

		Industry Rank	Sector Rank
ROA	-47.69%
ROE	N/A
ROIC	N/A

ROA(3y)-7.72%

ROA(5y)N/A

ROE(3y)-77.02%

ROE(5y)N/A

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

CANO does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	N/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5YN/A

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

CANO does not have a ROIC to compare to the WACC, probably because it is not profitable.

The number of shares outstanding for CANO has been reduced compared to 1 year ago.

CANO has a worse debt/assets ratio than last year.

2.2 Solvency

CANO has an Altman-Z score of 0.33. This is a bad value and indicates that CANO is not financially healthy and even has some risk of bankruptcy.

CANO has a Altman-Z score of 0.33. This is in the lower half of the industry: CANO underperforms 66.09% of its industry peers.

		Industry Rank	Sector Rank
Debt/Equity	N/A
Debt/FCF	N/A
Altman-Z	0.33

ROIC/WACCN/A

WACC5.13%

2.3 Liquidity

CANO has a Current Ratio of 0.40. This is a bad value and indicates that CANO is not financially healthy enough and could expect problems in meeting its short term obligations.

With a Current ratio value of 0.40, CANO is not doing good in the industry: 91.30% of the companies in the same industry are doing better.

CANO has a Quick Ratio of 0.40. This is a bad value and indicates that CANO is not financially healthy enough and could expect problems in meeting its short term obligations.

CANO has a Quick ratio of 0.40. This is amonst the worse of the industry: CANO underperforms 91.30% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	0.4
Quick Ratio	0.4

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

CANO shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -343.95%.

Looking at the last year, CANO shows a very strong growth in Revenue. The Revenue has grown by 25.69%.

The Revenue has been growing by 96.42% on average over the past years. This is a very strong growth!

EPS 1Y (TTM)-343.95%

EPS 3YN/A

EPS 5YN/A

EPS growth Q2Q-299.43%

Revenue 1Y (TTM)25.69%

Revenue growth 3Y96.42%

Revenue growth 5YN/A

Revenue growth Q2Q18.51%

3.2 Future

CANO is expected to show a very negative growth in Earnings Per Share. In the coming years, the EPS will decrease by -50.04% yearly.

CANO is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 2.24% yearly.

EPS Next Y-1383.78%

EPS Next 2Y-122.5%

EPS Next 3Y-50.04%

EPS Next 5YN/A

Revenue Next Year16.84%

Revenue Next 2Y1.95%

Revenue Next 3Y2.61%

Revenue Next 5Y2.24%

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

CANO reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.

Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for CANO. No positive earnings are expected for the next year.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A

4.2 Price Multiples

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	N/A

4.3 Compensation for Growth

CANO's earnings are expected to decrease with -50.04% in the coming years. This may justify a cheaper valuation.

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y-122.5%

EPS Next 3Y-50.04%

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

CANO does not give a dividend.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

CANO HEALTH INC

NYSE:CANO (2/2/2024, 7:04:00 PM)

Premarket: 1.17 -1.13 (-49.13%)

2.3

-0.05 (-2.13%)

Chartmill FA Rating

GICS SectorHealth Care

GICS IndustryGroupHealth Care Equipment & Services

GICS IndustryHealth Care Providers & Services

Earnings (Last)

Earnings (Next)

Inst Owners

Inst Owner Change

Ins Owners

Ins Owner Change

Market Cap12.44M

Analysts

Price Target

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Dividend Growth(5Y)

Div Incr Years

Div Non Decr Years

Ex-Date

Surprises & Revisions

EPS beat(2)

Avg EPS beat(2)

Min EPS beat(2)

Max EPS beat(2)

EPS beat(4)

Avg EPS beat(4)

Min EPS beat(4)

Max EPS beat(4)

EPS beat(8)

Avg EPS beat(8)

EPS beat(12)

Avg EPS beat(12)

EPS beat(16)

Avg EPS beat(16)

Revenue beat(2)

Avg Revenue beat(2)

Min Revenue beat(2)

Max Revenue beat(2)

Revenue beat(4)

Avg Revenue beat(4)

Min Revenue beat(4)

Max Revenue beat(4)

Revenue beat(8)

Avg Revenue beat(8)

Revenue beat(12)

Avg Revenue beat(12)

Revenue beat(16)

Avg Revenue beat(16)

PT rev (1m)

PT rev (3m)

EPS NQ rev (1m)

EPS NQ rev (3m)

EPS NY rev (1m)

EPS NY rev (3m)

Revenue NQ rev (1m)

Revenue NQ rev (3m)

Revenue NY rev (1m)

Revenue NY rev (3m)

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA

EPS(TTM)

EPS(NY)

Fwd EY

FCF(TTM)

FCFY

OCF(TTM)

OCFY

SpS

BVpS

TBVpS

PEG (NY)N/A

PEG (5Y)N/A

Profitability

		Industry Rank	Sector Rank
ROA	-47.69%
ROE	N/A
ROCE
ROIC
ROICexc
ROICexgc
OM	N/A
PM (TTM)	N/A
GM	N/A
FCFM

ROA(3y)

ROA(5y)

ROE(3y)

ROE(5y)

ROIC(3y)

ROIC(5y)

ROICexc(3y)

ROICexc(5y)

ROICexgc(3y)

ROICexgc(5y)

ROCE(3y)

ROCE(5y)

ROICexcg growth 3Y

ROICexcg growth 5Y

ROICexc growth 3Y

ROICexc growth 5Y

OM growth 3Y

OM growth 5Y

PM growth 3Y

PM growth 5Y

GM growth 3Y

GM growth 5Y

F-Score

Asset Turnover2.56

Health

		Industry Rank	Sector Rank
Debt/Equity	N/A
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio	0.4
Quick Ratio	0.4
Altman-Z

F-Score

WACC

ROIC/WACC

Cap/Depr(3y)

Cap/Depr(5y)

Cap/Sales(3y)

Cap/Sales(5y)

Profit Quality(3y)

Profit Quality(5y)

Growth

EPS 1Y (TTM)-343.95%

EPS 3YN/A

EPS 5Y

EPS growth Q2Q

EPS Next Y-1383.78%

EPS Next 2Y

EPS Next 3Y

EPS Next 5Y

Revenue 1Y (TTM)25.69%

Revenue growth 3Y96.42%

Revenue growth 5Y

Revenue growth Q2Q

Revenue Next Year

Revenue Next 2Y

Revenue Next 3Y

Revenue Next 5Y

EBIT growth 1Y

EBIT growth 3Y

EBIT growth 5Y

EBIT Next Year

EBIT Next 3Y

EBIT Next 5Y

FCF growth 1Y

FCF growth 3Y

FCF growth 5Y

OCF growth 1Y

OCF growth 3Y

OCF growth 5Y

CANO HEALTH INC (CANO)

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens